Memantine vs Nivolumab

## Memantine vs Nivolumab: Overview

This comparison examines the pharmacological differences between **Memantine** and **Nivolumab**.

## Mechanism of Action

**Memantine**: Non-competitive NMDA receptor antagonist.

**Nivolumab**: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

## Pharmacokinetics

**Half-life**: Memantine — 60-80 hours; Nivolumab — 27 days.

## Chemical Properties

**Molecular Formula**: Memantine — C12H21N; Nivolumab — N/A.

**Molecular Weight**: Memantine — 179.3080 g/mol; Nivolumab — N/A.

**Type**: Memantine — Small molecule; Nivolumab — Antibody.